NEWS & MEDIA
Press Releases
-
Hyku Biosciences Appoints John Gustofson to its Board of Directors
November 12, 2024
GLOBENEWSWIRE -
Hyku Biosciences, a Covalent Precision Medicine Company, Announces CEO Transition for its Next Phase of Growth
March 11, 2024
GLOBENEWSWIRE -
Hyku Biosciences Launches With $56M to Advance its Covalent Medicines Platform to Expand the Boundaries of Drug Discovery
September 19, 2023
ACCESSWIRE
Publications
-
Hyku: tapping new targets by taking chemoproteomics beyond cysteine
October 10, 2023
BIOCENTURY -
The emerging role of mass spectrometry-based proteomics in drug discovery
March 29, 2022
NATURE -
Development and biological applications of sulfur–triazole exchange (SuTEx) chemistry
January 19, 2021
RSC CHEMICAL BIOLOGY -
Covalent drugs go from fringe field to fashionable endeavor: Designing molecules that make bonds with their biological targets is in vogue
November 9, 2020
CHEMICAL & ENGINEERING NEWS